Literature DB >> 15141139

Smoking and Hodgkin lymphoma risk in women United States.

Sally L Glaser1, Theresa H M Keegan, Christina A Clarke, Lyndsey A Darrow, Scarlett L Gomez, Ronald F Dorfman, Risa B Mann, Joseph A DiGiuseppe, Richard F Ambinder.   

Abstract

OBJECTIVE: Smoking has received little consideration as a risk factor for Hodgkin lymphoma (HL) in women, despite recent significant findings in men and gender differences in HL incidence. We investigated the association of HL with lifetime cigarette smoking and household environmental tobacco smoke (ETS) exposure in women.
METHODS: In data from a population-based case-control study in women ages 19-79, we analyzed HL risk associated with self-reported smoking and household ETS exposure in 312 diagnostically re-reviewed cases and 325 random-digit dialing controls using logistic regression. Epstein-Barr virus (EBV) presence was determined in tumors of 269 cases.
RESULTS: In 253 cases compared to 254 controls ages 19-44, risks of HL overall, and of nodular sclerosis and EBV-negative HL, were increased 50% with ETS exposure in childhood; for 11 cases of mixed cellularity (MC) HL, current smoking and adult ETS exposure also increased risk; for 24 cases of EBV-positive HL, risk was elevated for current smoking, greater smoking intensity and duration, and ETS exposure. In 59 cases and 71 controls ages 45-79, most smoking characteristics did not appear to affect risk.
CONCLUSIONS: Apparent effects of current smoking on risks of MC HL and EBV-positive HL and of household ETS on risk of all HL in young adult females may broaden the evidence implicating tobacco smoke exposures in HL etiology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15141139     DOI: 10.1023/B:CACO.0000027497.00558.e2

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  8 in total

Review 1.  Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph).

Authors:  M Kamper-Jørgensen; K Rostgaard; S L Glaser; S H Zahm; W Cozen; K E Smedby; S Sanjosé; E T Chang; T Zheng; C La Vecchia; D Serraino; A Monnereau; E V Kane; L Miligi; P Vineis; J J Spinelli; J R McLaughlin; P Pahwa; J A Dosman; M Vornanen; L Foretova; M Maynadie; A Staines; N Becker; A Nieters; P Brennan; P Boffetta; P Cocco; H Hjalgrim
Journal:  Ann Oncol       Date:  2013-06-19       Impact factor: 32.976

2.  A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma.

Authors:  Wendy Cozen; Ann S Hamilton; Peng Zhao; Muhammad T Salam; Dennis M Deapen; Bharat N Nathwani; Lawrence M Weiss; Thomas M Mack
Journal:  Blood       Date:  2009-09-08       Impact factor: 22.113

3.  Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.

Authors:  K C Simon; I A F van der Mei; K L Munger; A Ponsonby; J Dickinson; T Dwyer; P Sundström; A Ascherio
Journal:  Neurology       Date:  2010-04-07       Impact factor: 9.910

4.  Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations.

Authors:  Sally L Glaser; Margaret L Gulley; Christina A Clarke; Theresa H Keegan; Ellen T Chang; Sarah J Shema; Fiona E Craig; Joseph A Digiuseppe; Ronald F Dorfman; Risa B Mann; Hoda Anton-Culver; Richard F Ambinder
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

Review 5.  Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer.

Authors:  Francisco Aguayo; Enrique Boccardo; Alejandro Corvalán; Gloria M Calaf; Rancés Blanco
Journal:  Infect Agent Cancer       Date:  2021-06-30       Impact factor: 2.965

6.  Clinical, molecular, and environmental risk factors for hodgkin lymphoma.

Authors:  Alison Maggioncalda; Neha Malik; Pareen Shenoy; Melody Smith; Rajni Sinha; Christopher R Flowers
Journal:  Adv Hematol       Date:  2010-11-29

7.  Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case-control study (EPILYMPH).

Authors:  H Besson; P Brennan; N Becker; S De Sanjosé; A Nieters; R Font; M Maynadié; L Foretova; P L Cocco; A Staines; M Vornanen; P Boffetta
Journal:  Br J Cancer       Date:  2006-07-04       Impact factor: 7.640

8.  Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence.

Authors:  Deniz Bakkalci; Yumeng Jia; Joanne R Winter; Joanna Ea Lewis; Graham S Taylor; Helen R Stagg
Journal:  J Glob Health       Date:  2020-06       Impact factor: 4.413

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.